Tag: PIRAMAL CRITICAL CARE

According to chairperson Nandini Piramal, Piramal Pharma will expand its injectables pipeline to enhance growth. The company launched Chlorpromazine Hydrochloride recently, with its complex hospital generics business seeing a 14% growth in Q3. Reports indicate their share in inhalation anesthetics and a focus on new products suggest promising future revenue, aiming for $2 billion by…